encyclopedia of medical concepts
ψ
ψ

Stalevo

under Carbidopa
More information in Books or onNLM PubMed
More on Carbidopa Definition: An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.      Other names Methyldopahydrazine; MK486; MK485; MK 486; MK 485; MK-486; MK-485; Lodosyn; Lodosin; Carbidopa, (S)-Isomer; Carbidopa, (R)-Isomer Drugs: LODOSYN
SubstanceCAS Registry & nameCategoriesSourceDrugs*
Stalevo
  Levodopa, carbidopa & entacapone (Catechols), intended as improved therapy for Parkinson Disease 		0   *Carbidopa *Catechols *Levodopa Drug Combinations Neurology 2004 Jan 13;62(1 Suppl 1):S64-71 STALEVO 50; STALEVO 75; STALEVO 150; STALEVO 200; STALEVO 125

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy